Everything we’ve written on GLP-1s, weight loss, and metabolic optimization. Real clinical data, real timelines, no hype. Start with the dosing and timeline guides if you’re new.
51 articles in this category
The mechanism of action behind the weight-loss revolution, and why it's not just "about eating less."
Why GLP-1s are uniquely effective for perimenopausal women, and how to combine with HRT.
PCOS is driven by insulin resistance, exactly what GLP-1s treat. Here's what the research shows.
Starting doses, titration schedules, maintenance, and what to do when side effects or plateaus show up.
Plateaus are rarely "the drug stopped." Six common causes, and the protocol to break through.
STEP-4 showed two-thirds of weight returns at 12 months without a maintenance plan. The protocol that keeps the results.
Nausea, constipation, muscle loss, "Ozempic face", what's real, what's hype, and how to prevent the problems that are avoidable.
Visceral fat is the dangerous kind. GLP-1 therapy reduces it disproportionately to total weight loss, explaining a chunk of the cardiovascular and metabolic benefits.
Step-by-step protocol for preserving muscle through aggressive weight loss on GLP-1 therapy. Specific numbers, specific sequences.
5-day half-life. ~25-day full clearance. Practical implications for missed doses, surgery, and stopping.
Same molecule. Different brand routes. Plus where compounded tirzepatide fits in.
It's rapid-fat-loss face, not drug-specific face. The prevention strategy and what to do if it's already happened.
The 7 real causes of weight loss stalls, and exactly how to restart fat loss when the scale stops moving.
The GLP-1 receptor isn't just in your pancreas. It's in your brain, gut, heart, kidney, immune cells, and bone. Understanding the biology explains the body-wide effects.
GLP-1 therapy has produced weight losses approaching bariatric surgery for some patients, without the surgical risk. Here's the honest comparison in 2026.
PCOS is increasingly understood as a metabolic disorder for many patients. GLP-1 therapy treats the root rather than the surface, and the cascade of improvements is often dramatic.
The SURMOUNT-OSA trial showed tirzepatide cut apnea-hypopnea index roughly in half. The mechanism, the implications, and why this matters even for patients without diagnosed apnea.
GLP-1 receptors are expressed throughout the brain. Understanding the central effects explains why these drugs change cravings, mood, and possibly cognition.
Patients on semaglutide and tirzepatide consistently report drinking less. The mesolimbic reward circuit dampening is the mechanism.
Many patients started on GLP-1 therapy for weight loss become pregnant unexpectedly. The mechanism: restored ovulation. Here's what's known and what's not.
Cardiovascular outcome trials of GLP-1 agonists have changed how we think about these medications. Heart disease event rates drop by ~14-20%, and the mechanism is much more than weight loss.
Many women find menopausal weight gain resistant to the strategies that worked in their 30s and 40s. The hormonal shift requires hormonal-aware treatment.
Non-alcoholic fatty liver disease (now MASLD/MASH) is the most common chronic liver disease worldwide. GLP-1 therapy is becoming a primary treatment.
Lower hs-CRP and IL-6 are among the most reproducible findings in GLP-1 trials. The mechanism is direct, not just downstream of weight loss, and explains a chunk of the cardiovascular and cogniti...
Patients on GLP-1 therapy commonly report less knee, hip, and back pain. Some of that is mechanical, less weight on joints. Some is anti-inflammatory.
Slowed gastric emptying is the most-discussed gut effect, but GLP-1 affects motility from stomach to colon. The full picture explains every GI side effect.
Skin changes on GLP-1 therapy fall in two camps: structural changes from rapid fat loss ("Ozempic face") and inflammatory improvements (acne, redness). Both have explanations.
Cancer concerns dominated early GLP-1 discourse. Ten years later, what does the data actually show, about thyroid, pancreas, colon, breast, and overall cancer risk?
Diabetic kidney disease is the leading cause of kidney failure. GLP-1 therapy slows its progression substantially, through inflammation reduction, blood pressure improvement, and direct renal effe...
Dopamine drives the wanting that turns food cues into food searches. GLP-1 therapy dampens that wanting at the receptor level.
"Food noise" was a folk term until pharmacology validated it. Here's the molecular story behind why GLP-1 medications quiet the constant mental chatter about food.
GLP-1 receptors are expressed in the hippocampus. Brain insulin resistance is implicated in Alzheimer's. Multiple large trials are testing the connection.
Rapid weight loss reduces bone density. The mechanism, the trial data, and how to protect bone during GLP-1 therapy.
GLP-1 therapy improves insulin sensitivity through multiple mechanisms, only some of which are downstream of weight loss. Here's what's direct and what's indirect.
Lipid changes on GLP-1 therapy are favorable but specific. Triglycerides drop dramatically; LDL changes are modest; ApoB, the cleaner marker, improves substantially.
HbA1c reflects 3 months of glycemic control. GLP-1 therapy moves it dramatically, and the trajectory predicts long-term outcomes.
Higher GLP-1 doses produce more weight loss, up to a point. Beyond that, side effects accumulate without proportional benefit. Finding the personal optimal dose matters.
Patients on GLP-1 therapy who resistance train end up with dramatically different body composition than those who don't. Same scale weight, very different bodies.
Adults with ADHD often have characteristic eating patterns driven by dopamine biology. The same biology GLP-1 therapy modulates.
After 12+ months on GLP-1 therapy, some patients notice the effect waning. The mechanism is receptor desensitization, and protocols exist to manage it.
SURMOUNT-OSA cut apneas in half. The first major pharmaceutical advance in OSA management in decades.
The data on muscle loss with GLP-1s, and the protein-training-hormone protocol that closes the gap.
What 20% body weight loss does for mortality, metabolic health, and quality of life, backed by SELECT and SURMOUNT data.
How the drug that started it all works, why it's effective, and what to expect if you consider it.
Take Find My Protocol, the 5-minute intake routes you to the right physician and the right protocol for your case.